AAPL   317.94 (-0.10%)
MSFT   183.25 (+1.02%)
FB   225.09 (-0.16%)
GOOGL   1,433.52 (+1.08%)
AMZN   2,442.37 (+1.72%)
NVDA   355.02 (+4.58%)
CGC   17.37 (-20.03%)
BABA   207.39 (+3.96%)
MU   47.91 (+3.10%)
GE   6.57 (-3.10%)
TSLA   835.00 (+3.62%)
AMD   53.80 (+3.98%)
T   30.86 (-0.64%)
ACB   14.08 (-8.21%)
F   5.71 (-2.39%)
GILD   77.83 (+3.33%)
DIS   117.30 (+0.47%)
NFLX   419.73 (+1.52%)
BAC   24.12 (-2.98%)
BA   145.85 (-2.65%)
AAPL   317.94 (-0.10%)
MSFT   183.25 (+1.02%)
FB   225.09 (-0.16%)
GOOGL   1,433.52 (+1.08%)
AMZN   2,442.37 (+1.72%)
NVDA   355.02 (+4.58%)
CGC   17.37 (-20.03%)
BABA   207.39 (+3.96%)
MU   47.91 (+3.10%)
GE   6.57 (-3.10%)
TSLA   835.00 (+3.62%)
AMD   53.80 (+3.98%)
T   30.86 (-0.64%)
ACB   14.08 (-8.21%)
F   5.71 (-2.39%)
GILD   77.83 (+3.33%)
DIS   117.30 (+0.47%)
NFLX   419.73 (+1.52%)
BAC   24.12 (-2.98%)
BA   145.85 (-2.65%)
AAPL   317.94 (-0.10%)
MSFT   183.25 (+1.02%)
FB   225.09 (-0.16%)
GOOGL   1,433.52 (+1.08%)
AMZN   2,442.37 (+1.72%)
NVDA   355.02 (+4.58%)
CGC   17.37 (-20.03%)
BABA   207.39 (+3.96%)
MU   47.91 (+3.10%)
GE   6.57 (-3.10%)
TSLA   835.00 (+3.62%)
AMD   53.80 (+3.98%)
T   30.86 (-0.64%)
ACB   14.08 (-8.21%)
F   5.71 (-2.39%)
GILD   77.83 (+3.33%)
DIS   117.30 (+0.47%)
NFLX   419.73 (+1.52%)
BAC   24.12 (-2.98%)
BA   145.85 (-2.65%)
AAPL   317.94 (-0.10%)
MSFT   183.25 (+1.02%)
FB   225.09 (-0.16%)
GOOGL   1,433.52 (+1.08%)
AMZN   2,442.37 (+1.72%)
NVDA   355.02 (+4.58%)
CGC   17.37 (-20.03%)
BABA   207.39 (+3.96%)
MU   47.91 (+3.10%)
GE   6.57 (-3.10%)
TSLA   835.00 (+3.62%)
AMD   53.80 (+3.98%)
T   30.86 (-0.64%)
ACB   14.08 (-8.21%)
F   5.71 (-2.39%)
GILD   77.83 (+3.33%)
DIS   117.30 (+0.47%)
NFLX   419.73 (+1.52%)
BAC   24.12 (-2.98%)
BA   145.85 (-2.65%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Pacira BiosciencesAkcea TherapeuticsDicerna PharmaceuticalsTheravance BiopharmaKaryopharm Therapeutics
SymbolNASDAQ:PCRXNASDAQ:AKCANASDAQ:DRNANASDAQ:TBPHNASDAQ:KPTI
Price Information
Current Price$43.95$14.90$21.57$25.25$18.80
52 Week RangeBuyBuyBuyBuyBuy
Beat the Market™ Rank
Overall Score1.61.21.71.51.8
Analysis Score3.33.44.53.44.4
Community Score2.82.43.02.43.0
Dividend Score0.00.00.00.00.0
Ownership Score0.00.01.01.01.0
Earnings & Valuation Score1.90.00.00.60.6
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$54.50$34.67$34.20$37.00$30.63
% Upside from Price Target24.00% upside132.66% upside58.55% upside46.53% upside62.90% upside
Trade Information
Market Cap$1.88 billion$1.51 billion$1.59 billion$1.58 billion$1.36 billion
Beta1.311.331.841.541.6
Average Volume656,282246,036673,564392,4631,655,896
Sales & Book Value
Annual Revenue$421.03 million$488.54 million$23.90 million$73.41 million$40.89 million
Price / Sales4.403.0866.7121.7033.62
Cashflow$1.70 per share$0.50 per shareN/AN/AN/A
Price / Cash25.8629.55N/AN/AN/A
Book Value$8.88 per share$5.04 per share$2.41 per share($2.50) per share$2.27 per share
Price / Book4.952.968.95-10.108.28
Profitability
Net Income$-11,020,000.00$40.77 million$-120,460,000.00$-236,460,000.00$-199,590,000.00
EPS$0.86$0.48($1.76)($4.25)($3.22)
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E Ratio22.77N/AN/AN/AN/A
P/E Growth$1.50N/AN/AN/AN/A
Net Margins-0.02%-8.59%-213.04%-280.80%-316.53%
Return on Equity (ROE)13.89%-6.70%-74.79%N/A-208.07%
Return on Assets (ROA)6.06%-5.92%-22.53%-47.43%-59.78%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.94%0.03%0.12%N/A0.75%
Current Ratio5.37%12.63%2.90%5.45%7.46%
Quick Ratio4.63%12.25%2.90%5.45%7.44%
Ownership Information
Institutional Ownership PercentageN/A20.15%82.78%88.47%96.14%
Insider Ownership Percentage5.80%1.50%21.28%5.90%13.26%
Miscellaneous
Employees51824878363332
Shares Outstanding42.12 million101.07 million73.92 million63.09 million73.12 million
Next Earnings Date8/13/2020 (Estimated)8/4/2020 (Estimated)8/13/2020 (Estimated)7/29/2020 (Estimated)8/4/2020 (Estimated)
OptionableOptionableOptionableOptionableOptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.